Phosphoindoles as HIV inhibitors

Details for Australian Patent Application No. 2005305609 (hide)

Owner Idenix Pharmaceuticals, Inc.

Inventors Roland, Arlene; Dousson, Cyril; Alexandre, Francois-Rene; Storer, Richard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005305609

PCT Pub. Number WO2006/054182

Priority 60/711,445 25.08.05 US; 60/711,565 26.08.05 US; 60/611,061 17.09.04 US

Filing date 16 September 2005

Wipo publication date 26 May 2006

Acceptance publication date 6 October 2011

International Classifications

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/054182 Priority application(s): WO2006/054182

7 June 2007 Amendment Made

  The nature of the amendment is: Amend priority details from 60/611,061 16 Sep 2004 US to 60/611,061 17 Sep 2004 US 2005309870 Valspar Sourcing, Inc. The nature of the amendment is: Amend the co-inventor name Killilea, Howard T. to Killilea, T. Howard

6 October 2011 Application Accepted

  Published as AU-B-2005305609

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305610-Enzymatically synthesized marine phospholipids

2005305607-Apparatus for offshore transfer of fluid